A quality API is the key to developing quality medicine: Creating high-quality active pharmaceutical ingredients (APIs) at competitive prices is one of our core activities at Extrovis.
We focus on unique drug delivery technologies and drug-device combinations designed to improve the efficacy, safety, compliance as well as bioavailability of drugs where absorption could be limited due to solubility, permeability, and/or stability problems.
Our API R&Ds are equipped to deliver medium to high complex APIs, spread over an area of 500 sqm and supported by some of the most talented and experienced scientists in the industry.
Extrovis AG
Chamerstrasse 176,
6300 Zug, Switzerland
corporate@extrovis.com
+41 41 740 1120
